Stivarga Prices, Coupons and Patient Assistance Programs
Stivarga (regorafenib) is a member of the multikinase inhibitors drug class and is commonly used for Colorectal Cancer, Gastrointestinal Stromal Tumor and Hepatocellular Carcinoma.
This Stivarga price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Stivarga oral tablet 40 mg is around $18,139 for a supply of 84, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
Stivarga is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Stivarga availability.
|84 (3 x 28 each)||$215.94||$18,138.89|
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount CardPrint Now
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Stivarga Coupons and Rebates
Stivarga offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Stivarga Co-Pay Program: Eligible commercially insured patients may pay $0 per prescription with savings of up to $25,000 per calendar year; for additional information contact the program at 866-581-4992.
|Number of uses:||12 times within calendar year|
Patient Assistance Programs for Stivarga
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Stivarga (regorafenib) Tablet
Provider: Bayer US Patient Assistance Foundation Free Drug Program
- Must have no prescription coverage for needed medication
- Not disclosed
- Medically appropriate condition/diagnosis
- Must be residing in the US or Puerto Rico
- Eligibility determined on a case-by-case basis.
- Stivarga (regorafenib) Tablet
More about Stivarga (regorafenib)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 3 Reviews
- Drug class: multikinase inhibitors
- FDA Approval History